Catalyst Wire Dossier Catalyst Wire Dossier

NNC0519-0130

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for NNC0519-0130, covering 2025-06-18 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Looking Into Blood Levels of the Medicine NNC0519-0130 in the Body in Participants With Normal or Reduced Kidney Function [Phase 1]

See pricing